Benefit of long-term treatment with teriflunomide on disability outcomes: results from TEMSO and TOWER

被引：0
|
作者：
Lublin, F. [1 ]
Freedman, M. S. [2 ,3 ]
Comi, G. [4 ]
Miller, A. E. [5 ]
Thangavelu, K. [6 ]
Truffinet, P. [7 ]
Kappos, L. [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Sanofi Genzyme, Cambridge, MA USA
[7] Sanofi Genzyme, Chilly Mazarin, France
[8] Univ Hosp Basel, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
基金：
新加坡国家研究基金会; 美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P691
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [31] Long-term safety and efficacy of teriflunomide in patients with relapsing forms of multiple sclerosis in the TEMSO extension trial
    Freedman, M.
    Wolinsky, J.
    Comi, G.
    Kappos, L.
    Olsson, T.
    Miller, A.
    Benamor, M.
    Dukovic, D.
    Liang, J.
    Truffinet, P.
    O'Connor, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 225 - 225
  • [32] Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide
    Sprenger, Till
    Kappos, Ludwig
    Radue, Ernst-Wilhelm
    Gaetano, Laura
    Mueller-Lenke, Nicole
    Wuerfel, Jens
    Poole, Elizabeth M.
    Cavalier, Steven
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1207 - 1216
  • [33] Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study
    Miller, Aaron E.
    Vermersch, Patrick
    Kappos, Ludwig
    Comi, Giancarlo
    Freedman, Mark S.
    Oh, Jiwon
    de Seze, Jerome
    Truffinet, Philippe
    Benamor, Myriam
    Purvis, Annie
    Wolinsky, Jerry S.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 131 - 138
  • [34] Long-term safety and efficacy of teriflunomide Nine-year follow-up of the randomized TEMSO study
    O'Connor, Paul
    Comi, Giancarlo
    Freedman, Mark S.
    Miller, Aaron E.
    Kappos, Ludwig
    Bouchard, Jean-Pierre
    Lebrun-Frenay, Christine
    Mares, Jan
    Benamor, Myriam
    Thangavelu, Karthinathan
    Liang, Jinjun
    Truffinet, Philippe
    Lawson, Victoria J.
    Wolinsky, Jerry S.
    [J]. NEUROLOGY, 2016, 86 (10) : 920 - 930
  • [35] Is There Long-Term Benefit From Stimulant Treatment for ADHD?
    Pliszka, Steven R.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (09): : 685 - 686
  • [36] long-term retrospective analysis of multiple sclerosis treatment and disability outcomes
    Arnett, Simon
    Chew, Sin Hong
    Sobarun, Namrata
    Prosser, Michelle
    o'maley, Timothy
    Broadley, Simon
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 613 - 613
  • [37] Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network
    Iaffaldano, Pietro
    Lucisano, Giuseppe
    Butzkueven, Helmut
    Hillert, Jan
    Hyde, Robert
    Koch-Henriksen, Nils
    Magyari, Melinda
    Pellegrini, Fabio
    Spelman, Tim
    Sorensen, Per Soelberg
    Vukusic, Sandra
    Trojano, Maria
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (10) : 1543 - 1555
  • [38] Evaluating the effect of teriflunomide in subgroups defined by prior treatment: pooled analyses of the phase 3 TEMSO and TOWER studies
    Freedman, M. S.
    Dukovic, D.
    Benamor, M.
    Truffinet, P.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 87 - 87
  • [39] Effect of teriflunomide in subgroups defined by prior treatment: pooled analysis of the phase 3 TEMSO, TOWER, and TENERE studies
    Comi, G.
    Freedman, M. S.
    Meca-Lallana, J.
    Vermersch, P.
    Kim, B.
    Parajeles, A.
    Edwards, K.
    Gold, R.
    Overell, J.
    Korideck, H.
    Chavin, J.
    Poole, E.
    Coyle, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 682 - 682
  • [40] LONG-TERM ECONOMIC OUTCOMES OF MODERN TREATMENT: SICK LEAVE AND WORK DISABILITY
    Petersson, I. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 4 - 4
12345